Relevant bibliographies by topics / Neuropsychological tests / Journal articles

Journal articles on the topic 'Neuropsychological tests'

To see the other types of publications on this topic, follow the link: Neuropsychological tests.
Author: Grafiati
Published: 4 June 2021
Last updated: 30 July 2024

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Neuropsychological tests.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

YAMASHITA, HIKARU. "Neuropsychological tests." Japanese Journal of Rehabilitation Medicine 31, no. 9 (1994): 651–58. http://dx.doi.org/10.2490/jjrm1963.31.651.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

MD, O. D., B. Myrvang, and R. B. PhD. "Neuropsychological tests in HIV." Neurology 42, no. 10 (October 1, 1992): 2055. http://dx.doi.org/10.1212/wnl.42.10.2055-c.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Miller, E. N., P. S. PhD, and B. Visscher. "Neuropsychological tests in HIV." Neurology 42, no. 10 (October 1, 1992): 2056. http://dx.doi.org/10.1212/wnl.42.10.2056.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Maeshima, Shinichiro, and Aiko Osawa. "Outline of Neuropsychological Tests(Brain Surgery and Neuropsychological Function)." Japanese Journal of Neurosurgery 18, no. 4 (2009): 264–70. http://dx.doi.org/10.7887/jcns.18.264.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Rozzini, R., O. Zanetti, and M. Trabucchi. "Delirium Induced by Neuropsychological Tests." Journal of the American Geriatrics Society 37, no. 7 (July 1989): 666. http://dx.doi.org/10.1111/j.1532-5415.1989.tb01263.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Gasquoine, Philip G. "Race-Norming of Neuropsychological Tests." Neuropsychology Review 19, no. 2 (March 19, 2009): 250–62. http://dx.doi.org/10.1007/s11065-009-9090-5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Freides, David. "Desirable features in neuropsychological tests." Journal of Psychopathology and Behavioral Assessment 7, no. 4 (December 1985): 351–64. http://dx.doi.org/10.1007/bf00960708.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Hiskey, Syd. "Ecological validity of neuropsychological tests." Clinical Psychology Forum 1, no. 194 (February 2009): 17–21. http://dx.doi.org/10.53841/bpscpf.2009.1.194.17.

Full text
Abstract:
This paper explores when it might be important to employ ecologically valid neuropsychological tests and outlines some of the evidence and issues clinical psychologists might consider during measure selection.
APA, Harvard, Vancouver, ISO, and other styles
9

Boller, F., and G. Dalla Barba. "Neuropsychological tests in Alzheimer’s disease." Aging Clinical and Experimental Research 13, no. 3 (June 2001): 210–20. http://dx.doi.org/10.1007/bf03351479.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

ALLEN, DANIEL N., GERALD GOLDSTEIN, and ERIN WARNICK. "A consideration of neuropsychologically normal schizophrenia." Journal of the International Neuropsychological Society 9, no. 1 (January 2003): 56–63. http://dx.doi.org/10.1017/s135561770391006x.

Full text
Abstract:
Neuropsychological deficits are considered by many to be core features of schizophrenia. However, about 20% of patients with schizophrenia appear to have normal neuropsychological function. This study investigates this subgroup by comparing a “neuropsychologically normal” schizophrenia group to a non-schizophrenic, non-brain damaged patient comparison (PC) sample, and to patients with definitive brain damage who performed normally on neuropsychological testing. All patients completed the Halstead-Reitan Neuropsychological Test Battery and were classified as neuropsychologically normal or impaired using the Average Impairment Rating (AIR). In a sample of 113 patients with schizophrenia, 19.5% were classified as neuropsychologically normal. The brain damaged neuropsychologically normal group (BD-NN) consisted of 14.3% of 124 subjects. These groups were compared with a patient non-schizophrenic, non-brain damaged group who were selected on the basis of having an Average Impairment Rating in the neuropsychologically normal range. The neuropsychologically normal schizophrenic group performed less well than the non-brain damaged, non-schizophrenic patient comparison group on a number of tests, indicating that patients in this group may not be completely neuropsychologically normal, and would be better characterized as “high-functioning” or near normal. The results are discussed in regard to possible neurobiological differences between neuropsychologically impaired and intact schizophrenic patients, and implications for course and outcome. (JINS, 2003, 9, 56–63.)
APA, Harvard, Vancouver, ISO, and other styles
11

MOFFITT, TERRIE E., DONALD R. LYNAM, and PHIL A. SILVA. "NEUROPSYCHOLOGICAL TESTS PREDICTING PERSISTENT MALE DELINQUENCY*." Criminology 32, no. 2 (May 1994): 277–300. http://dx.doi.org/10.1111/j.1745-9125.1994.tb01155.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
12

Alptekin, Cem. "Neuropsychological aspects of foreign language tests." Language Learning Journal 3, no. 1 (March 1991): 71–72. http://dx.doi.org/10.1080/09571739185200251.

Full text
APA, Harvard, Vancouver, ISO, and other styles
13

Sabatino, M., O. Pino, and V. La Grutta. "P445 Magnetic stimulation and neuropsychological tests." Electroencephalography and Clinical Neurophysiology 99, no. 4 (October 1996): 378. http://dx.doi.org/10.1016/0013-4694(96)88620-2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
14

Zucchella, Chiara, Angela Federico, Alice Martini, Michele Tinazzi, Michelangelo Bartolo, and Stefano Tamburin. "Neuropsychological testing." Practical Neurology 18, no. 3 (February 22, 2018): 227–37. http://dx.doi.org/10.1136/practneurol-2017-001743.

Full text
Abstract:
Neuropsychological testing is a key diagnostic tool for assessing people with dementia and mild cognitive impairment, but can also help in other neurological conditions such as Parkinson’s disease, stroke, multiple sclerosis, traumatic brain injury and epilepsy. While cognitive screening tests offer gross information, detailed neuropsychological evaluation can provide data on different cognitive domains (visuospatial function, memory, attention, executive function, language and praxis) as well as neuropsychiatric and behavioural features. We should regard neuropsychological testing as an extension of the neurological examination applied to higher order cortical function, since each cognitive domain has an anatomical substrate. Ideally, neurologists should discuss the indications and results of neuropsychological assessment with a clinical neuropsychologist. This paper summarises the rationale, indications, main features, most common tests and pitfalls in neuropsychological evaluation.
APA, Harvard, Vancouver, ISO, and other styles
15

Harrell, Murphy, Vasilios Ikonomou, Carolina Pereira Osorio, Nanako Hawley, Jasmin Pizer, Paola Asencio-Ortiz, and Benjamin Hill. "A-102 How Valuable Are Clinical Neuropsychological Assessments? A Meta-Analysis of Neuropsychological Tests Compared to Neuroimaging." Archives of Clinical Neuropsychology 37, no. 6 (August 17, 2022): 1254. http://dx.doi.org/10.1093/arclin/acac060.102.

Full text
Abstract:
Abstract Objective: This meta-analysis summarized and compared the effect sizes of neuroimaging to diagnose Alzheimer’s Disease (ad) to neuropsychological tests to diagnose ad and traumatic brain injury (TBI). Data Selection: EBSCO network was searched for original research examining the efficacy of neuroimaging for ad and common neuropsychological tests for ad and TBI within the last 5 years. Other inclusion/exclusion criteria were: clinical and control group, efficacy statistics, and sufficient descriptive statistical information (e.g., mean, SD) for each group. Data Synthesis: Of 3488 studies identified, 56 were retained for meta-analyses (502 effect sizes extracted; 3856 clinical and 4112 control participants represented). Using comprehensive meta-analysis software and random-effects modeling, results indicated the neuroimaging effect size [Hedges g = −1.670] was not significantly different than the neuropsychological test efficacy [Hedges g = −1.548; Q(1) = 0.213, p = 0.644]. Within neuropsychological tests, the ad neuropsychological test effect size [Hedges g = −2.213] was significantly different than the TBI neuropsychological test efficacy [Hedges g = −0.649; Q(1) = 42.821, p = 0.000]. There was a significant degree of between-study heterogeneity for both neuroimaging [Q(21) = 298.655, p < 0.001, I2 = 93.303] and neuropsychological [Q(39) = 860.715, p < 0.001, I2 = 95.469] studies. Conclusions: The diagnostic efficacy of neuroimaging and neuropsychological tests were both substantial and non-significantly different from one another. These findings are consistent with prior research suggesting neuropsychological tests are as effective as neuroimaging and provides clinicians and consumers convincing evidence that neuropsychological tests are a reliable diagnostic tool among people with acquired and neurodegenerative brain disorders.
APA, Harvard, Vancouver, ISO, and other styles
16

Farmer, Mary E., Lon R. White, Steven J. Kittner, Edith Kaplan, Elizabeth Moes, Pat Mcnamara, Michael M. Wolz, Philip A. Wolf, and Manning Feinleib. "Neuropsychological Test Performance in Framingham: A Descriptive Study." Psychological Reports 60, no. 3_part_2 (June 1987): 1023–40. http://dx.doi.org/10.1177/0033294187060003-201.1.

Full text
Abstract:
In 1976–1978, a battery of eight neuropsychologic tests was administered to 2,123 participants in the Framingham Study aged 55 to 89 yr. The battery was designed to sample multiple areas of cognitive function including language skills, memory, learning, reproduction of designs, attention, and abstract thinking. Performance is described for several groups in this population: a large community-dwelling sample, those with hearing impairments, and those with documented strokes. Performance is described by age, sex, and education strata for the community sample. This normative information should be useful for interpreting individual test performance on neuropsychological tests.
APA, Harvard, Vancouver, ISO, and other styles
17

Woo, Ellen. "Computerized Neuropsychological Assessments." CNS Spectrums 13, S16 (2008): 14–17. http://dx.doi.org/10.1017/s1092852900026985.

Full text
Abstract:
Computer-based measures to evaluate cognition have been used with growing frequency in recent years. These batteries are shown to be useful for identifying mild cognitive impairment (MCI) and dementia. There are few requirements to administer these tests. All that is typically needed is a computer, a response pad for patients to input their answers, and an examiner. In many cases, the examiner does not need to be a trained neuropsychologist. These computer-based assessments should yield a score report detailing the patient’s cognitive profile.An important advantage of computerized assessments over standard paper-and-pencil testing is that they can provide precise measurement at the millisecond level. This can be a more sensitive measure of cognitive impairment, especially in high-functioning older adults and in patients with milder levels of cognitive deficit. Computer tests also have a shorter assessment time. Many batteries take <1 hour to administer, whereas many standard neuropsychological batteries require >4 hours to complete. The presentation of items in some batteries can be adapted to patients’ performance levels to avoid floor effects (the test restricts how low a patients’ scores can be) and ceiling effects (the test restricts how high scores can be). Computer tests have increased standardization; they are administered the same way every time. Scoring is automatic, meaning the results are available immediately and human scoring error is reduced. Examiner effects are reduced, which is an important advantage because clinicians may differ in how they administer standard tests, which may impact patients’ responses. In addition, the batteries are easily transported, and multiple tasks can be made available on a single computer.
APA, Harvard, Vancouver, ISO, and other styles
18

Wouters, Hans, Bregje Appels, Wiesje M. van der Flier, Jos van Campen, Martin Klein, Aeilko H. Zwinderman, Ben Schmand, Willem A. van Gool, Philip Scheltens, and Robert Lindeboom. "Improving the Accuracy and Precision of Cognitive Testing in Mild Dementia." Journal of the International Neuropsychological Society 18, no. 2 (December 30, 2011): 314–22. http://dx.doi.org/10.1017/s1355617711001755.

Full text
Abstract:
AbstractThe CAMCOG, ADAS-cog, and MMSE, designed to grade global cognitive ability in dementia have inadequate precision and accuracy in distinguishing mild dementia from normal ageing. Adding neuropsychological tests to their scale might improve precision and accuracy in mild dementia. We, therefore, pooled neuropsychological test-batteries from two memory clinics (ns = 135 and 186) with CAMCOG data from a population study and 2 memory clinics (n = 829) and ADAS-cog data from 3 randomized controlled trials (n = 713) to estimate a common dimension of global cognitive ability using Rasch analysis. Item difficulties and individuals’ global cognitive ability levels were estimated. Difficulties of 57 items (of 64) could be validly estimated. Neuropsychological tests were more difficult than the CAMCOG, ADAS-cog, and MMSE items. Most neuropsychological tests had difficulties in the ability range of normal ageing to mild dementia. Higher than average ability levels were more precisely measured when neuropsychological tests were added to the MMSE than when these were measured with the MMSE alone. Diagnostic accuracy in mild dementia was consistently better after adding neuropsychological tests to the MMSE. We conclude that extending dementia specific instruments with neuropsychological tests improves measurement precision and accuracy of cognitive impairment in mild dementia. (JINS, 2012, 18, 314–322)
APA, Harvard, Vancouver, ISO, and other styles
19

Rasmussen, Kirsten, Roger Almvik, and Sten Levander. "Performance and Strategy Indices of Neuropsychological Tests." Journal of Forensic Neuropsychology 2, no. 2 (June 2001): 29–43. http://dx.doi.org/10.1300/j151v02n02_03.

Full text
APA, Harvard, Vancouver, ISO, and other styles
20

Allen, Daniel N., Felito Aldarondo, Gerald Goldstein, Stephen G. Huegel, Mark Gilbertson, and Daniel P. Van Kammen. "Construct Validity of Neuropsychological Tests in Schizophrenia." Assessment 5, no. 4 (December 1998): 365–74. http://dx.doi.org/10.1177/107319119800500406.

Full text
APA, Harvard, Vancouver, ISO, and other styles
21

Snaedal, J. "Neuropsychological tests and SPECT in dementing disorders." Archives of Clinical Neuropsychology 13, no. 1 (February 1998): 34–35. http://dx.doi.org/10.1016/s0887-6177(98)90414-0.

Full text
APA, Harvard, Vancouver, ISO, and other styles
22

Letz, Richard. "Continuing Challenges for Computer-based Neuropsychological Tests." NeuroToxicology 24, no. 4-5 (August 2003): 479–89. http://dx.doi.org/10.1016/s0161-813x(03)00047-0.

Full text
APA, Harvard, Vancouver, ISO, and other styles
23

Fjell, Anders M., and Kristine B. Walhovd. "P3a and Neuropsychological ‘Frontal’ Tests in Aging." Aging, Neuropsychology, and Cognition 10, no. 3 (September 2003): 169–81. http://dx.doi.org/10.1076/anec.10.3.169.16450.

Full text
APA, Harvard, Vancouver, ISO, and other styles
24

Snaedal, J., T. J. Jonsdottir, and G. J. Eliasson. "Neuropsychological tests and SPECT in dementing disorders." Archives of Clinical Neuropsychology 13, no. 1 (February 1, 1998): 34–35. http://dx.doi.org/10.1093/arclin/13.1.34a.

Full text
APA, Harvard, Vancouver, ISO, and other styles
25

Lundin, K., and N. DeFilippis. "Time requirements for psychological and neuropsychological tests." Archives of Clinical Neuropsychology 14, no. 1 (January 1, 1999): 85. http://dx.doi.org/10.1093/arclin/14.1.85.

Full text
APA, Harvard, Vancouver, ISO, and other styles
26

ALBERT, MARILYN S., MARK B. MOSS, RUDOLPH TANZI, and KENNETH JONES. "Preclinical prediction of AD using neuropsychological tests." Journal of the International Neuropsychological Society 7, no. 5 (July 2001): 631–39. http://dx.doi.org/10.1017/s1355617701755105.

Full text
Abstract:
Normals (N = 42) and patients with mild memory difficulty (N = 123) were given a neuropsychological test battery, and then followed annually for 3 years to determine which individuals developed sufficient functional change that they met clinical criteria for AD. Twenty-three of the 123 participants with mild memory difficulty converted to a diagnosis of probable Alzheimer's disease (AD) within 3 years of follow-up. Four of the 20 neuropsychological measures obtained at baseline, were useful in discriminating the groups on the basis of their status 3 years after the tests were given. The 4 discriminating tests pertained to assessments of memory and executive function. When the controls were compared to the individuals with memory impairments who ultimately developed AD (the converters), the accuracy of discrimination was 89%, based on the neuropsychological measures at baseline. The discrimination of the controls from the individuals with mild memory problems who did not progress to the point where they met clinical criteria for probable AD over the 3 years of follow-up (the Questionables) was 74% and the discrimination of the questionables from the converters was 80%. The specific tests that contributed to these discriminations, in conjunction with recent neuropathological and neuroimaging data from preclinical cases, have implications for which brain regions may be affected during the prodromal phase of AD. (JINS, 2001, 7, 631–639.)
APA, Harvard, Vancouver, ISO, and other styles
27

Meyers, John E., and Martin L. Rohling. "CT and MRI Correlations with Neuropsychological Tests." Applied Neuropsychology 16, no. 4 (November 23, 2009): 237–53. http://dx.doi.org/10.1080/09084280903098752.

Full text
APA, Harvard, Vancouver, ISO, and other styles
28

Nici, J. "A Compendium of Neuropsychological Tests, 2nd ed." Archives of Neurology 57, no. 2 (February 1, 2000): 278. http://dx.doi.org/10.1001/archneur.57.2.278.

Full text
APA, Harvard, Vancouver, ISO, and other styles
29

Nikolai, Tomáš, and Ondřej Bezdíček. "Memory disorders and neuropsychological memory tests in clinical practice." Neurologie pro praxi 19, no. 6 (December 10, 2018): 405–10. http://dx.doi.org/10.36290/neu.2018.129.

Full text
APA, Harvard, Vancouver, ISO, and other styles
30

Weber, Erica, Yael Goverover, and John DeLuca. "Beyond cognitive dysfunction: Relevance of ecological validity of neuropsychological tests in multiple sclerosis." Multiple Sclerosis Journal 25, no. 10 (August 30, 2019): 1412–19. http://dx.doi.org/10.1177/1352458519860318.

Full text
Abstract:
In neurological diseases such as multiple sclerosis (MS), a neuropsychological assessment is often requested to assist clinicians in evaluating the role of cognition in a patient’s level of everyday functioning. To be effective in this charge, it is assumed that performance on neuropsychological tests is related to how a person may function in everyday life, and the question is often asked: “Are neuropsychological tests ecologically valid?” In this review, we synthesize the literature that examines the use of neuropsychological tests to assess functioning across a variety of everyday functioning domains in MS (i.e. driving, employment, instrumental activities of daily living (IADLs)). However, we critically examine the usefulness of asking this broad question regarding ecological validity, given the psychometric and conceptual pitfalls it may yield. While many neuropsychological tests may be generally considered “ecologically valid” in MS, it is much more helpful to specify for whom, under what circumstances, and to what degree.
APA, Harvard, Vancouver, ISO, and other styles
31

Holliday, S. L., and R. M. Costello. "Screening for neuropsychological deficits in gulf war veterans: MicroCog vs. standard neuropsychological tests." Archives of Clinical Neuropsychology 12, no. 4 (January 1, 1997): 338. http://dx.doi.org/10.1093/arclin/12.4.338.

Full text
APA, Harvard, Vancouver, ISO, and other styles
32

Moffitt, Terrie E. "The neuropsychology of conduct disorder." Development and Psychopathology 5, no. 1-2 (1993): 135–51. http://dx.doi.org/10.1017/s0954579400004302.

Full text
Abstract:
AbstractThis article reviews evidence from neuropsychological tests that brain dysfunction is a correlate of conduct disorder. Most studies report consistent findings of differential neuropsychological deficits for antisocial samples in verbal and “executive” functions. Neuropsychological measures are related to some of the best indicators of poor outcome for children with conduct symptoms, such as early onset, stability across time, hyperactive symptoms, and aggressiveness. Neuropsychological tests statistically predict variance in antisocial behavior independently of appropriate control variables. This article argues that neuropsychological variables warrant further study as possible causal factors for conduct disorder and presents one developmental perspective on how neuropsychological problems might contribute risk for conduct disorder.
APA, Harvard, Vancouver, ISO, and other styles
33

Kato, Akinobu, Yuki Watanabe, Kei Sawara, and Kazuyuki Suzuki. "Diagnosis of sub-clinical hepatic encephalopathy by Neuropsychological Tests (NP-tests)." Hepatology Research 38 (November 2008): S122—S127. http://dx.doi.org/10.1111/j.1872-034x.2008.00437.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
34

Mendes, Liliana, Artemisa Dores, Irene Carvalho, and Fernando Barbosa. "Common neuropsychological assessment measures as performance indicators in neuropsychological rehabilitation: An exploratory correlational study." PSYCHTECH & HEALTH JOURNAL 5, no. 2 (April 26, 2022): 30–41. http://dx.doi.org/10.26580/pthj.art39-2022.

Full text
Abstract:
This study aims to identify neuropsychological assessment measures that can better guide the selection and difficulty level adjustment of neuropsychological rehabilitation tasks for patients with acquired brain injury. Eight patients with acquired brain injury were recruited from one rehabilitation institution. The neuropsychological protocol included standard neuropsychological tests targeting attention, memory, and executive functions. After the assessment, the patients enrolled in an intensive online cognitive neuropsychological rehabilitation training program (80 sessions of 49 cognitive training and 31 affective and psychosocial intervention sessions). The association between the assessment results and the training outcomes was measured to explore which measures were better associated with specific training outcomes. This study suggests that the results of specific conventionally administered neuropsychological tests can be good indicators of the patients’ performance in the cognitive training of attention and working memory. On the other hand, none of the tests provided valuable data regarding the patients’ ability to perform the executive functioning training tasks, perhaps because those appeal to everyday situations, which are not adequately represented in the administered tests. More research is needed, especially regarding the executive function.
APA, Harvard, Vancouver, ISO, and other styles
35

Mambwe, L. Kalungwana. "Influence of Age and Education on Neuropsychological Tests in Zambia." Medical Journal of Zambia 44, no. 2 (June 11, 2017): 106–13. http://dx.doi.org/10.55320/mjz.44.2.273.

Full text
Abstract:
Objective: The purpose of this study is to explore the influence of age, education and reading ability on neuropsychological tests in Zambia.Methods and Materials: 324 adult participants were recruited from urban and rural areas in Zambia. They had an age range of 19-65 and education range of 5 – 19 years of schooling. The Zambia Neurobehavioural Test battery was administered.Results and Conclusion: Results showed that all Neurobehavioural test scores had a strong association with education and an inverse relationship with age. Education did not generally offer protection against age-related decline in neuropsychological functioning. Reading level predicted performance on neuropsychological tests better than years of schooling
APA, Harvard, Vancouver, ISO, and other styles
36

Kalungwana, Lisa. "Influence of Age and Education on Neuropsychological Tests in Zambia." Medical Journal of Zambia 44, no. 2 (June 9, 2017): 106–13. http://dx.doi.org/10.55320/mjz.44.2.71.

Full text
Abstract:
Objective: The purpose of this study is to explore the influence of age, education and reading ability on neuropsychological tests in Zambia. Methods and Materials: 324 adult participants were recruited from urban and rural areas in Zambia. They had an age range of 19 - 65 and education range of 5 – 19 years of schooling. The Zambia Neurobehavioural Test battery was administered. Results and Conclusion: Results showed that all test scores had a strong association with education and an inverse relationship with age. Education did not generally offer protection against age-related decline in neuropsychological functioning. Reading level predicted performance on neuropsychological tests better than years of schooling.
APA, Harvard, Vancouver, ISO, and other styles
37

BURGESS, PAUL W., NICK ALDERMAN, JON EVANS, HAZEL EMSLIE, and BARBARA A. WILSON. "The ecological validity of tests of executive function." Journal of the International Neuropsychological Society 4, no. 6 (November 1998): 547–58. http://dx.doi.org/10.1017/s1355617798466037.

Full text
Abstract:
Ninety-two mixed etiology neurological patients and 216 control participants were assessed on a range of neuropsychological tests, including 10 neuropsychological measures of executive function derived from 6 different tests. People who knew the patients well (relatives or carers) completed a questionnaire about the patient's dysexecutive problems in everyday life, and this paper reports the extent to which the tests predicted the patients' everyday life problems. All of the tests were significantly predictive of at least some of the behavioral and cognitive deficits reported by patients' carers. However, factor analysis of the patients' dysexecutive symptoms suggested a fractionation of the dysexecutive syndrome, with neuropsychological tests loading differentially on 3 underlying cognitive factors (Inhibition, Intentionality, and Executive Memory), supporting the conclusions that different tests measure different cognitive processes, and that there may be limits to the fractionation of the executive system. (JINS, 1998, 4, 547–558.)
APA, Harvard, Vancouver, ISO, and other styles
38

Skulskaya, N. I., M. V. Nadezhdina, Ye V. Osinceva, and M. N. Zhezher. "Gender aspects of mild cognitive impairment." Bulletin of Siberian Medicine 8, no. 3(2) (June 28, 2009): 36–38. http://dx.doi.org/10.20538/1682-0363-2009-3(2)-36-38.

Full text
Abstract:
Neuropsychological research and analysis of level testosterone and estradiol among men and women at age from 50 to 60 were carried out. Two groups were formed. The first group was of patients with complaints bad memory and concentration, and the second group was of patients with out any complaints. The change for certain of results the neuropsychological tests between two groups of patients were fixed. The results of long-term memory were more sensible. The correlation between different level of testosterone and results of neuropsychological tests among men and women was fixed. The correlation between level of estradiol and results of neuropsychological tests was not fixed.
APA, Harvard, Vancouver, ISO, and other styles
39

BARRASH, JOSEPH, ASHLEY STILLMAN, STEVEN W. ANDERSON, ERGUN Y. UC, JEFFREY D. DAWSON, and MATTHEW RIZZO. "Prediction of driving ability with neuropsychological tests: Demographic adjustments diminish accuracy." Journal of the International Neuropsychological Society 16, no. 4 (May 5, 2010): 679–86. http://dx.doi.org/10.1017/s1355617710000470.

Full text
Abstract:
AbstractDemographically adjusted norms generally enhance accuracy of inferences based on neuropsychological assessment. However, we hypothesized that demographic corrections diminish predictive accuracy for real-world activities with absolute cognitive demands. Driving ability was assessed with a 45-minute drive along a standardized on-road route in participants aged 65+ (24 healthy elderly, 26 probable Alzheimer’s disease, 33 Parkinson’s disease). Neuropsychological measures included: Trail-Making A and B, Complex Figure, Benton Visual Retention, and Block Design tests. A multiple regression model with raw neuropsychological scores was significantly predictive of driving errors (R2 = .199, p = .005); a model with demographically adjusted scores was not (R2 = .113, p = .107). Raw scores were more highly correlated with driving errors than were adjusted scores for each neuropsychological measure, and among healthy elderly and Parkinson’s patients. When predicting real-world activities that depend on absolute levels of cognitive abilities regardless of demographic considerations, predictive accuracy is diminished by demographic corrections. (JINS, 2010, 16, 679–686.)
APA, Harvard, Vancouver, ISO, and other styles
40

Libon, David J., Ganesh Baliga, Rod Swenson, and Rhoda Au. "Digital Neuropsychological Assessment: New Technology for Measuring Subtle Neuropsychological Behavior." Journal of Alzheimer's Disease 82, no. 1 (June 29, 2021): 1–4. http://dx.doi.org/10.3233/jad-210513.

Full text
Abstract:
Technology has transformed the science and practice of medicine. In this special mini-forum, data using digital neuropsychological technology are reported. All of these papers demonstrate how coupling digital technology with standard paper and pencil neuropsychological tests are able to extract behavior not otherwise obtainable. As digital assessment methods mature, early identification of persons with emergent neurodegenerative and other neurological illness may be possible.
APA, Harvard, Vancouver, ISO, and other styles
41

Burgess, A. P., M. Riccio, D. Jadresic, K. Pugh, J. Catalan, D. A. Hawkins, T. Baldeweg, E. Lovett, J. Gruzelier, and C. Thompson. "A longitudinal study of the neuropsychiatric consequences of HIV-1 infection in gay men. I Neuropsychological performance and neurological status at baseline and at 12-month follow-up." Psychological Medicine 24, no. 4 (November 1994): 885–95. http://dx.doi.org/10.1017/s003329170002897x.

Full text
Abstract:
SynopsisThe aim of this study was to determine whether HIV infection is associated with neurological or neuropsychological impairment in the asymptomatic and early symptomatic stages of disease. Subjects included 61 gay men (41 HIV −, 20 HIV +) who were assessed at the time of requesting their first HIV test and again 12 months later. The assessments at baseline were conducted double-blind to HIV serostatus. Measures included a neuropsychological battery, neurological examination and full psychiatric assessment. There were no differences between the asymptomatic HIV + and HIV − groups at baseline or at follow-up in terms of mean scores on neuropsychological tests. Mean scores were within the normal range for all neuropsychological tests for both groups. Multiple regression analysis was used to predict each individual's performance at follow-up on the basis of their baseline performance, psychiatric state, neurological history and drug use for each of the neuropsychological tests. HIV + subjects were more likely than control subjects to perform at a significantly lower level at follow-up on one or more tests than predicted on the basis of their baseline performance.
APA, Harvard, Vancouver, ISO, and other styles
42

Kabaeva, A. R., and A. N. Boyko. "Informative value of neuropsychological tests for multiple sclerosis." Neurology, Neuropsychiatry, Psychosomatics 12, no. 1S (August 5, 2020): 33–37. http://dx.doi.org/10.14412/2074-2711-2020-1s-33-37.

Full text
Abstract:
Cognitive impairment (CI) occurs in 43–70% of patients with multiple sclerosis (MS) at both early and late stages of the disease. Cognitive deficit leads to disability regardless of the patient's physical condition and correlates with lower quality of life. A number of tests and batteries with good psychometric measures are used to assess the neuropsychological status of patients with MS. However, the validation and active clinical introduction of new or already existing neuropsychological tests remain relevant. Timely diagnosis of CI will be able to define the correct tactics of managing patients with MS and to monitor the efficiency of treatment.
APA, Harvard, Vancouver, ISO, and other styles
43

Ahles, Tim A., Andrew J. Saykin, Charlotte T. Furstenberg, Bernard Cole, Leila A. Mott, Karen Skalla, Marie B. Whedon, et al. "Neuropsychologic Impact of Standard-Dose Systemic Chemotherapy in Long-Term Survivors of Breast Cancer and Lymphoma." Journal of Clinical Oncology 20, no. 2 (January 15, 2002): 485–93. http://dx.doi.org/10.1200/jco.2002.20.2.485.

Full text
Abstract:
PURPOSE: The primary purpose of this study was to compare the neuropsychologic functioning of long-term survivors of breast cancer and lymphoma who had been treated with standard-dose systemic chemotherapy or local therapy only. PATIENTS AND METHODS: Long-term survivors (5 years postdiagnosis, not presently receiving cancer treatment, and disease-free) of breast cancer or lymphoma who had been treated with systemic chemotherapy (breast cancer: n = 35, age, 59.1 ± 10.7 years; lymphoma: n = 36, age, 55.9 ± 12.1 years) or local therapy only (breast cancer: n = 35, age, 60.6 ± 10.5 years; lymphoma: n = 22, age, 48.7 ± 11.7 years) completed a battery of neuropsychologic and psychologic tests (Center for Epidemiological Study–Depression, Spielberger State-Trait Anxiety Inventory, and Fatigue Symptom Inventory). RESULTS: Multivariate analysis of variance, controlling for age and education, revealed that survivors who had been treated with systemic chemotherapy scored significantly lower on the battery of neuropsychologic tests compared with those treated with local therapy only (P < .04), particularly in the domains of verbal memory (P < .01) and psychomotor functioning (P < .03). Survivors treated with systemic chemotherapy were also more likely to score in the lower quartile on the Neuropsychological Performance Index (39% v 14%, P < .01) and to self-report greater problems with working memory on the Squire Memory Self-Rating Questionnaire (P < .02). CONCLUSION: Data from this study support the hypothesis that systemic chemotherapy can have a negative impact on cognitive functioning as measured by standardized neuropsychologic tests and self-report of memory changes. However, analysis of the Neuropsychological Performance Index suggests that only a subgroup of survivors may experience long-term cognitive deficits associated with systemic chemotherapy.
APA, Harvard, Vancouver, ISO, and other styles
44

Bruni, Amalia C., Francesca M. Dovetto, Raffaele Guarasci, Alessia Guida, Valentina Laganà, Anna Chiara Pagliaro, Simona Schiattarella, and Paola Sciutto. "Test neuropsicologici per l’analisi dei deficit linguistici." CHIMERA: Revista de Corpus de Lenguas Romances y Estudios Lingüísticos 9 (July 31, 2022): 21–47. http://dx.doi.org/10.15366/chimera2022.9.002.

Full text
Abstract:
This contribution aims at showing the relevance of linguistic analytical tools applied to neuropsychological assessment tests. After a presentation of main neuropsychological tests, a pilot study concerning one case study is presented, where a mixed methods (quantitative and qualitative) approach is applied. This pilot study is intended to be functional for further methodological reflection. The paper urges thus for a greater integration between neuropsychological assessment and linguistic analysis.
APA, Harvard, Vancouver, ISO, and other styles
45

Tomasevic, Snezana, Danka Filipovic, and Nada Naumovic. "Neuropsychological tests in stroke patients during medical rehabilitation." Medical review 55, no. 7-8 (2002): 321–24. http://dx.doi.org/10.2298/mpns0208321t.

Full text
Abstract:
Introduction There is a necessity for neuropsychological research in everyday clinical practice in stroke patients. Considering the fact that cognitive functions are very frequently impaired in stroke patients, there is a need to examine the level of impairment during recovery and rehabilitation therapy. Material and methods This study included 80 right-handed examinees of certain age and sex distribution. The clinical part of the study evaluated the cognitive recovery of patients by using Mini-Mental State examination and the complex reaction time test during the rehabilitation treatment, four weeks on average. The aim of this study was to establish the characteristics and dynamics of complex reaction time Mini-Mental State examination in patients during medical rehabilitation following brain stroke. Results The average values of Mini-Mental State at the beginning of treatment were 25.90 and at the end of treatment they were 28.93 (variation coefficient less than 30). Growth of average values of Mini-Mental State examination, during the rehabilitation treatment was 10.47%. In the group of patients after stroke, values of complex reaction time at the end of treatment were significantly shortened (p<0.05), but not to the levels established in the control group. Discussion and conclusion The overall results indicate that after rehabilitation treatment there is a statistically significant improvement in cognitive recovery in all patients. Improvement of complex reaction time at the end of treatment is conditioned with complex changes in the neural system. The results of studies point to the significance of early application of facilitatory techniques, as well as neuropsychological rehabilitation of patients after brain stroke.
APA, Harvard, Vancouver, ISO, and other styles
46

Gansler, David A., Mark Varvaris, and David J. Schretlen. "The use of neuropsychological tests to assess intelligence." Clinical Neuropsychologist 31, no. 6-7 (May 30, 2017): 1073–86. http://dx.doi.org/10.1080/13854046.2017.1322149.

Full text
APA, Harvard, Vancouver, ISO, and other styles
47

Howieson, Diane. "Current limitations of neuropsychological tests and assessment procedures." Clinical Neuropsychologist 33, no. 2 (January 4, 2019): 200–208. http://dx.doi.org/10.1080/13854046.2018.1552762.

Full text
APA, Harvard, Vancouver, ISO, and other styles
48

Smith, Robert C., J. Rosenberger, E. Tabor, and I. Alter. "NEUROLOGICAL AND NEUROPSYCHOLOGICAL TESTS IN NON-RESPONDING SCHIZOPHRENICS." Clinical Neuropharmacology 15 (1992): 260B. http://dx.doi.org/10.1097/00002826-199202001-00501.

Full text
APA, Harvard, Vancouver, ISO, and other styles
49

Guskiewicz, Kevin. "Keynote - Are Concussions Out - Smarting the Neuropsychological Tests?" Medicine & Science in Sports & Exercise 40, Supplement (May 2008): 33. http://dx.doi.org/10.1249/01.mss.0000320765.22120.d0.

Full text
APA, Harvard, Vancouver, ISO, and other styles
50

Hart, Stephen D., Adelle E. Forth, and Robert D. Hare. "Performance of criminal psychopaths on selected neuropsychological tests." Journal of Abnormal Psychology 99, no. 4 (November 1990): 374–79. http://dx.doi.org/10.1037/0021-843x.99.4.374.

Full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the bibliographies on the topic 'Neuropsychological tests' for other source types:
Dissertations / Theses Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography